Surgical Oncology

1. Front Matter

   Pages i-xi

   PDF

2. Prospective randomized trials in melanoma: Defining contemporary surgical roles

   • Merrick I. Ross

   Pages 1-27

3. Advances in rectal cancer treatment

   • John M. Skibber

   Pages 29-49

4. Molecular and surgical advances in pediatric tumors

   • Cynthia A. Corpron, Richard J. Andrassy

   Pages 51-69

5. Advances in reconstruction for cancer patients

   • Mark A. Schusterman, Geoffrey L. Robb, Helen E. Tadjalli

   Pages 71-89

6. New developments in soft tissue sarcoma

   • Peter W. T. Pisters, Barry W. Feig, Denis H. Y. Leung, Murray F. Brennan

   Pages 91-107

7. Advances in the diagnosis and treatment of adenocarcinoma of the pancreas

   • Douglas B. Evans, Jeffrey E. Lee, Peter W. T. Pisters, Chusilp Charnsangavej, Lee M. Ellis, Paul J. Chiao et al.

   Pages 109-125

8. Recent advances in bone sarcomas

   • Alan W. Yasko, Mark E. Johnson

   Pages 127-147

9. Thyroid carcinoma

   • Ann M. Gillenwater, Randal S. Weber

   Pages 149-169

10. Changing trends in the diagnosis and treatment of early breast cancer

    • Kelly K. Hunt, Merrick I. Ross

    Pages 171-201

11. Classification, staging, and management of non-Hodgkin’s lymphomas

    • Paul F. Mansfield, Kelly K. Hunt

    Pages 203-211

12. Multiple endocrine neoplasia

    • Julie A. Miller, Jeffrey A. Norton

    Pages 213-225

13. Advances in the diagnosis and treatment of gastrointestinal neuroendocrine tumors

    • Jeffrey E. Lee, Douglas B. Evans

    Pages 227-238

14. Contemporary Approaches to Gastric Carcinoma

    • Blake Cady

    Pages 239-252

15. New strategies in locally advanced breast cancer

    • S. Eva Singletary, Kapil Dhingra, Di-Hua Yu

    Pages 253-271

16. Biliary tract cancer

    • Steven A. Curley

    Pages 273-307

17. Minimally invasive surgery in surgical oncology

    • Jeffrey W. Milsom, Pierenrico Marchesa, Andrea Vignali

    Pages 309-329

18. Prognostic factors in surgical resection for hepatocellular carcinoma

    • Barry J. Roseman, Mark S. Roh

    Pages 331-345

19. Colon cancer

    • David M. Ota

    Pages 347-356

20. Back Matter

    Pages 357-371

    PDF

Among the standard oncology modalities, surgical oncology is singular in that it lacks a separate board certification or even an added qualification mecha­ nism. 'Card-carrying' surgical oncologists are certified by the American Board of Surgery, as are all other general surgeons. What distinguishes the surgical oncologist is a set of cognitive skills rather than a specific armamentarium of surgical techniques. This different conceptual framework is derived from ex­ tensive additional training that leads to an in-depth understanding of the natural history and biologic behavior of the various solid tumor systems. Equipped with this perspective, the surgical oncologist is particularly well positioned to integrate the various available therapeutic modalities into a coherent care program for the solid tumor patient. As a central theme, the chapters of this book demonstrate that increasingly sophisticated diagnostic and staging approaches are helping to move chemo­ therapy and radiotherapy into the preoperative neoadjuvant setting. This fundamental alteration is based on the awareness that even early-stage solid tumor disease is frequently systemic at the time of presentation, at least on a subclinical level. And although the primary tumor may be controllable by surgery with radiotherapy, the uncontrolled (and initially clinically unappar­ ent) distant disease ultimately determines patient survival. The other perspec­ tive driving the neoadjuvant approach is an emerging awareness that for most solid tumor systems, neoadjuvant treatment responses can facilitate less muti­ lating surgery with comparable levels of local disease control.

• Staging
• carcinoma
• classification
• neuroendocrine tumor
• surgery
• surgical oncology

• M.D. Anderson Cancer Center, The University of Texas, Houston, USA

  Raphael E Pollock

Policies and ethics